Form D · Other Technology

rMark Bio, Inc.

Chicago, IL · CIK 0001730006

Offering snapshot reported Oct 14, 2020 · SEC filing

Reported sold
$2.77M
Offering amount: $4M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 3, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.39M$2.77MOct 16, 2019: $1,000,000.00Oct 16, 2019Oct 14, 2020: $2,772,223.00Oct 14, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,000,000 → $2,772,223
  • Reported investors2 → 8

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 14, 2020Amendment$2,772,223$1,772,223vs Oct 16, 20198SEC filing
Oct 16, 2019Initial$1,000,000No comparison2SEC filing
Sep 10, 2018Amendment$1,769,665$1,669,665vs Feb 5, 201825SEC filing
Feb 5, 2018Initial$100,000No comparison17SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-351136

Source: Form D, filed Oct 14, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mark Achier Director
Mark Achler Director
Lev Becker Director, Executive
John Clyman Director
Jason Smith Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
222 W. Merchandise Mart Plaza Suite 1230
Chicago, IL, 60654